m6A调节器介导的RNA甲基化修饰在扩大心肌病中重塑免疫微环境
Zhi Luo1, Jun Cheng1, Yanggan Wang1,2,3
1Department of Geriatrics, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, China.
Journal of cellular physiology
|July 21, 2023
概括
扩张性心肌病 (DCM) 与免疫系统障碍有关. 通过IGFBP2介导的RNA甲基化会恶化免疫微环境,增加DCM风险,并建议IGFBP2作为治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 心脏病学 心脏病学
背景情况:
- 扩张性心肌病 (DCM) 的发病与免疫微环境障碍有关.
- N6-甲基氨酸 (m6A) RNA甲基化影响免疫细胞功能和抗瘤免疫力,可能破坏免疫微环境.
研究的目的:
- 研究m6ARNA甲基化在DCM中免疫微环境障碍中的作用.
- 确定关键的m6A调节剂及其对DCM病原发生的影响.
主要方法:
- 单样样本基因组丰富分析 (ssGSEA) 用于量化免疫细胞透.
- 单细胞RNA测序 (scRNA-Seq) 用于识别关键的m6A调节者.
- doxorubicin (Dox) 诱导的DCM小鼠模型用于体内验证.
主要成果:
- 在DCM心肌中,CD8+ T淋巴细胞,NK细胞,单细胞和B+淋巴细胞的透增加.
- IGFBP2被确定为DCM的关键调节者,与其他m6A相关因素相互作用.
- IGFBP2介导的RNA甲基化加剧了免疫微环境,激活了免疫通路,增加了DCM风险.
结论:
- IGFBP2介导的RNA甲基化重塑免疫微环境,有助于DCM的发展.
- IGFBP2为DCM治疗提供了一个潜在的治疗点.
相关概念视频
Cardiomyopathy IV: Restrictive Cardiomyopathy
12
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12
Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Epigenetic Regulation
31.1K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.1K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
16
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16


